Dysregulation of U12-Type Splicing in Lupus Neutrophils - Summary - MDSpire

Alterations in U12-Type RNA Splicing in Neutrophils of Systemic Lupus Erythematosus Patients

  • By

  • Luz P. Blanco

  • Binod Regmi

  • Carmelo Carmona-Rivera

  • Yudong Liu

  • Xiantao Wang

  • Philip M. Carlucci

  • Monica M. Jackson

  • Zerai Manna

  • Sarfaraz Hasni

  • Markus Hafner

  • Hong-Wei Sun

  • Mariana J. Kaplan

  • July 1, 2026

Share

Objective:

To investigate the role of U12-type RNA splicing abnormalities in neutrophils of patients with systemic lupus erythematosus (SLE) and their potential contribution to immune dysregulation.

Approach:
  • Neutrophil Isolation: Neutrophils and low-density granulocytes (LDGs) were isolated from blood samples of SLE patients and healthy controls.
  • Western Blot and Flow Cytometry: Western blotting and flow cytometry were used to analyze protein expression and Nox activity in neutrophils.
  • RNA Sequencing: RNA sequencing was performed to assess splicing abnormalities and gene expression in neutrophils.
  • Alternative Splicing Analysis: Alternative splicing events were analyzed using rMATS to identify differences in splicing patterns.
Key Findings:
  • Impaired Nox activity was observed in SLE LDGs, linked to reduced CYBA expression.
  • Evidence of U12 intron retention was found in SLE LDGs.
  • Broad splicing abnormalities were identified, particularly affecting U12-type introns.
Interpretation:

Limitations:
  • The study primarily focuses on neutrophils, which may not represent the entire immune landscape in SLE.
  • The sample size and diversity of SLE patients may limit the generalizability of the findings.
Conclusion:

Original Source(s)

Related Content